RECENT NEWS

The World Health Organization (WHO) is calling for an expansion of newborn screening for birth defects, highlighting how early detection and treatment can save lives and reduce lifelong disability for millions of children.

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational mRNA influenza vaccine helps the immune system recognise a wider range of influenza viruses than the standard vaccine, offering stronger and potentially longer-lasting protection.

MedTech Europe has published its detailed position on the European Commission’s proposed revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR), supporting the overall direction of the reform while calling for targeted changes to translate the framework into workable outcomes.

First of its kind research, led by Queen Mary University of London and funded by Cancer Research UK, shows that the human papillomavirus (HPV) vaccine is reducing cervical cancer deaths in England.

The Royal College of Pathologists (RCPath) presented seven Achievement Awards at its recent annual dinner, celebrating excellence across pathology practice, education, training and research.

The Institute of Biomedical Science (IBMS) hosted its Annual General Meeting (AGM) in London earlier this month, recognising and celebrating a number of its members for outstanding achievements.

The Medicines and Healthcare products Regulatory Agency (MHRA) is to launch a London-based regulatory sandbox - a secure environment designed to safely test AI-enabled devices in a real-world environment.

Proscia has introduced the Fifth Generation of its Concentriq platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based decisions.

Researchers at UCL and the Francis Crick Institute have identified 14 proteins in the blood that can predict lung cancer risk more than five years before diagnosis.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) have today announced a new liaison programme, marking a significant step forward in strengthening the regulatory partnership between the UK and the US.

A new UK-wide effectiveness review shows that the national NHS Infectious Diseases in Pregnancy Screening (IDPS) programmes have been highly effective in reducing the transmission of serious infections from mother to baby.

The UK Health Security Agency (UKHSA) has published its first Health Security Risk Assessment (HSRA), a publication which characterises the most significant health security risks facing the UK over the next five years.

Thousands of young people across England will get protection against meningococcal B (MenB) disease through a one-off vaccination programme launching ahead of the 2026 academic year.

The Royal College of Pathologists has responded to the UK National Screening Committee (NSC) consultation on antenatal screening for hepatitis C virus (HCV), supporting its inclusion in the UK national antenatal screening programme.

Debra Padgett, Clinical Pathology Lead at Northumbria Healthcare NHS Foundation Trust and immediate past-President of the IBMS (Institute of Biomedical Science) has been awarded the British Empire Medal (BEM) in His Majesty’s Birthday Honours for services to Biomedical Science in the NHS.

The Fleming Initiative has partnered with diagnostic firm Cepheid to launch TRACE-CPE, a two-and-a-half-year research study to improve testing for anti-microbial resistance.

The MHRA is publishing the results of an extensive public consultation which will inform the recommendations of the AI Commission and future regulations.

New research from the University of Liverpool shows that formaldehyde airborne concentrations in most NHS cell pathology departments are monitored infrequently and regularly exceed EU work exposure limits (WELs).

The National Pathology Imaging Co-Operative (NPIC), based at Leeds Teaching Hospital NHS Trust, hosted over 100 guests at it 2026 Summit meeting earlier this month to celebrate the achievements of its partnership of the NHS, academia and industry.

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.